Increased resistance to established tumor metastases after elimination of thymus - T-cell mediated suppression
Falk, R.E.; Nossal, N.; Samuel, E.S.; Falk, J.A.
Surgical Forum 28: 161-163
1977
ISSN/ISBN: 0071-8041 PMID: 310170 Document Number: 121283
Document emailed within 1 workday
Related Documents
North, R.J.; Awwad, M. 1987: T cell suppression as an obstacle to immunologically-mediated tumor regression: elimination of suppression results in regression Progress in Clinical and Biological Research 244: 345-358Gorbachev, A.V.; Kobayashi, H.; Kudo, D.; Tannenbaum, C.S.; Finke, J.H.; Shu, S.; Farber, J.M.; Fairchild, R.L. 2007: CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors Journal of Immunology 178(4): 2278-2286
Hanna, M.G. 1974: Immunologic aspects of BCG-mediated regression of established tumors and metastases in guinea pigs Seminars in Oncology 1(4): 319-335
Palubin, K.M.; Goodwin, B.L.; Niesen, M.I.; Le, E.A.; Osborne, A.R.; Blanck, G. 2006: A direct mechanistic link between growth control and a tumor cell immune function: increased interleukin-8 secretion accounts for elimination of Oct-1 antisense transformants from scid mice Anticancer Research 26(3a): 1733-1738
Boussiotis, V.A.; Lee, B.J.; Freeman, G.J.; Gribben, J.G.; Nadler, L.M. 1997: Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death Journal of Immunology 159(7): 3156-3167
Moser, G.; Cheng, G.; Abbas, A.K. 1986: Accessory cells in immune suppression. III. Evidence for two distinct accessory cell-dependent mechanisms of T lymphocyte-mediated suppression Journal of Immunology 137(10): 3074-3079
Komschlies, K.L.; Gregorio, T.A.; Gruys, M.E.; Back, T.C.; Faltynek, C.R.; Wiltrout, R.H. 1994: Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases Journal of Immunology 152(12): 5776-5784
Shin, H.S.; Hayden, M.; Langley, S.; Kaliss, N.; Smith, M.R. 1975: Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts Journal of Immunology 114(4): 1255-1263
Vanwijck, R.R.; Godrick, E.A.; Smith, H.G.; Goldweitz, J.; Wilson, R.E. 1971: Stimulation or suppression of metastases with graded doses of tumor cells Cancer Research 31(11): 1559-1563
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Tanigawa, N.; Mizuno, Y.; Hashimura, T.; Honda, K.; Satomura, K.; Hikasa, Y.; Niwa, O.; Sugahara, T.; Yoshida, O.; Kern, D.H. 1984: Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay Cancer Research 44(6): 2309-2312
Adler, A.; Keisari, Y.; Ofir, R. 1985: Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy Journal of the National Cancer Institute 74(2): 429-436
Collins, E.T.; Hershey, E.D.; Benjamin, D.C. 1985: Tolerance to azobenzenearsonate: idiotype-specific suppression, B cell dominance, and clonal elimination Journal of Immunology 135(2): 886-891
Liao, G.; Mao, Z.; Xu, P. 1998: Inhibition effects of tumor infiltrating lymphocytes from oral cancer on nude mice transplanted tumor established with human tongue carcinoma cell lines Zhonghua Kou Qiang Yi Xue Za Zhi 33(3): 146-148
Folch, H.; Waksman, B.H. 1974: The splenic suppressor cell. II. Suppression of mixed lymphocyte reaction by thymus-dependent adherent cells Journal of Immunology 113(1): 140-144
Joly-Pharaboz, M.O.; Fei, Z.L.; Bouillard, B.; Andre, J. 1990: Estradiol stimulation and inhibition of cell growth in new estrogen-sensitive cell lines and tumors established from the MtTF4 tumor Cancer Research 50(12): 3786-3794
Kurimoto, I.; Streilein, J.W. 1992: Cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha Journal of Immunology 148(10): 3072-3078
Mahmoud, A.A.; Warren, K.S.; Mandel, M.A. 1974: Marked suppression of cell-mediated immunity with niridazole: first report Surgical Forum 25(0): 514-516
Nehlsen, S.L.; Lalezari, P. 1977: Suppression of T-cell-mediated immune responses by sodium cyanate Transplantation Proceedings 9(1): 997-1000
Johnson, S.W.; Laub, P.B.; Beesley, J.S.; Ozols, R.F.; Hamilton, T.C. 1997: Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines Cancer Research 57(5): 850-856